Stay updated with breaking news from Sciences Stock Performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rhenman & Partners Asset Management AB boosted its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 165,000 shares of the medical research company’s stock after acquiring an additional 5,000 shares during […]
StockNews.com initiated coverage on shares of Applied DNA Sciences (NASDAQ:APDN – Free Report) in a report issued on Thursday. The firm issued a hold rating on the technology company’s stock. Separately, HC Wainwright increased their price objective on Applied DNA Sciences from $1.50 to $7.00 and gave the stock a buy rating in a research […]
Motley Fool Asset Management LLC cut its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.6% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,931 shares of the medical research company’s stock after selling 310 shares during the quarter. […]
Silvant Capital Management LLC lowered its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 13.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,119 shares of the medical research company’s stock after selling 2,181 […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) EVP Sarah Condella sold 2,000 shares of the stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $70.00, for a total transaction of $140,000.00. Following the completion of the sale, the executive vice president now directly owns […]